
Precios mayoristas disponibles para cuentas aprobadas
IGF-1 LR3 (Long R3 Insulin-like Growth Factor 1) is a synthetic 83-amino acid analog of human IGF-1 with an arginine substitution at position 3 and a 13-amino acid N-terminal extension. These modifications reduce IGF binding protein (IGFBP) affinity, resulting in significantly enhanced bioavailability and a prolonged half-life compared to native IGF-1. Extensively studied for cell proliferation, muscle hypertrophy, and anti-apoptotic signaling in preclinical models.
Todos los péptidos de Signal se someten a rigurosas pruebas de terceros y tienen una pureza garantizada ≥99%. Cada lote incluye un Certificado de Análisis (COA) verificado a través del sistema de verificación blockchain de AuthentiChain.
Los pedidos realizados antes de las 12PM EST se envían el mismo día mediante logística de cadena de frío. Los productos se envían en empaques aislados con hielo seco para mantener la integridad de la temperatura. La entrega estándar es de 1 a 3 días hábiles.
Las cuentas aprobadas tienen acceso a términos de pago flexibles que incluyen NET 30, transferencia bancaria y tarjeta de crédito. Los precios basados en volumen se aplican automáticamente al momento del pago según la cantidad de su pedido.
Por supuesto. Contacte a su gerente de cuenta dedicado o escriba a info@signalpeps.co con el nombre del producto y número de lote. Los COA también están disponibles digitalmente a través de nuestra insignia de verificación AuthentiChain en cada página de producto.
In-depth findings from peer-reviewed preclinical and clinical studies
IGF-1 LR3 (Long R3 Insulin-like Growth Factor 1) is a synthetic 83-amino acid analog of human IGF-1 featuring an arginine substitution at position 3 and a 13-amino acid N-terminal extension peptide. These structural modifications dramatically reduce binding to IGF binding proteins (IGFBPs), resulting in 2-3x greater potency and significantly prolonged bioavailability compared to native IGF-1. It is one of the most extensively studied growth factor analogs in preclinical research.
IGF-LR3 binds the IGF-1 receptor with similar affinity to native IGF-1 but with dramatically reduced IGFBP sequestration, resulting in a much larger fraction of free, biologically active peptide. This drives sustained PI3K/Akt and MAPK/ERK signaling cascades critical for cell survival, proliferation, and differentiation.
European Journal of Biochemistry (1990)IGF-LR3 is a potent stimulator of skeletal muscle hypertrophy, promoting myoblast proliferation, satellite cell activation, and myofiber protein synthesis. In preclinical models, systemic and local IGF-LR3 administration produced significant increases in muscle mass and cross-sectional fiber area.
Proceedings of the National Academy of Sciences (1998)Through sustained PI3K/Akt pathway activation, IGF-LR3 phosphorylates and inactivates pro-apoptotic factors including BAD, caspase-9, and Forkhead transcription factors. This provides robust anti-apoptotic protection to multiple cell types including neurons, cardiomyocytes, and pancreatic beta cells.
European Journal of Biochemistry (1990)The Arg3 substitution and 13-amino acid N-terminal extension reduce IGFBP binding by >100-fold compared to native IGF-1, dramatically increasing the circulating free fraction. This yields an effective half-life of approximately 20-30 hours versus ~15 minutes for native IGF-1.
European Journal of Biochemistry (1990)IGF-LR3 accelerates wound healing by stimulating fibroblast proliferation, collagen synthesis, and keratinocyte migration. It promotes angiogenesis through VEGF upregulation and has demonstrated enhanced bone fracture repair in preclinical models.
Growth Hormone & IGF Research (1996)IGF-LR3 stimulates glucose uptake in skeletal muscle through GLUT4 translocation via PI3K/Akt signaling, independent of insulin receptor activation. It also promotes amino acid uptake and net protein synthesis while inhibiting protein degradation.
European Journal of Biochemistry (1990)All findings above are sourced from peer-reviewed journals for educational reference. This product is for research purposes only — not for human consumption. Preclinical results may not translate to human outcomes.
Tres simples pasos para acceder a péptidos de investigación premium
Envíe una solicitud rápida con los datos de su empresa. Toma menos de 2 minutos.
Nuestro equipo revisa las solicitudes en 1–2 días hábiles. Recibirá un correo una vez aprobado.
Explore el catálogo, seleccione cantidades y pague. Los precios por volumen se aplican automáticamente.
Todos los productos son solo para investigación y uso en laboratorio. No destinados para consumo humano o animal. Solo profesionales calificados deben manejar estos productos.